These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26862122)

  • 21. [EUROASPIRE: survey conducted by the European Society of Cardiology on secondary prevention of coronary disease. Hungarian results].
    Ostör E; Jánosi A; Belatiny KA; Borbás S; Bradak A; Podmaniczky M
    Orv Hetil; 1999 Jan; 140(5):243-8. PubMed ID: 10064978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [EUROASPIRE-IV: European Society of Cardiology study of lifestyle, risk factors, and treatment approaches in patients with coronary artery disease: Data from Turkey].
    Tokgözoğlu L; Kayıkçıoğlu M; Altay S; Aydoğdu S; Barçın C; Bostan C; Çakmak HA; Çatakoğlu AB; Emet S; Ergene O; Kalkan AK; Kaya B; Tulunay Kaya C; Kaymaz C; Koylan N; Kültürsay H; Oğuz A; Özpelit E; Ünlü S
    Turk Kardiyol Dern Ars; 2017 Mar; 45(2):134-144. PubMed ID: 28424435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey.
    Kotseva K; Wood D; De Bacquer D;
    Eur J Prev Cardiol; 2018 Aug; 25(12):1242-1251. PubMed ID: 29873511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry.
    Kotseva K; De Backer G; De Bacquer D; Rydén L; Hoes A; Grobbee D; Maggioni A; Marques-Vidal P; Jennings C; Abreu A; Aguiar C; Badariene J; Bruthans J; Castro Conde A; Cifkova R; Crowley J; Davletov K; Deckers J; De Smedt D; De Sutter J; Dilic M; Dolzhenko M; Dzerve V; Erglis A; Fras Z; Gaita D; Gotcheva N; Heuschmann P; Hasan-Ali H; Jankowski P; Lalic N; Lehto S; Lovic D; Mancas S; Mellbin L; Milicic D; Mirrakhimov E; Oganov R; Pogosova N; Reiner Z; Stöerk S; Tokgözoğlu L; Tsioufis C; Vulic D; Wood D;
    Eur J Prev Cardiol; 2019 May; 26(8):824-835. PubMed ID: 30739508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Readiness for smoking cessation in coronary heart disease patients across Europe: Results from the EUROASPIRE III survey.
    Prugger C; Wellmann J; Heidrich J; De Bacquer D; De Backer G; Périer MC; Empana JP; Reiner Ž; Fras Z; Jennings C; Kotseva K; Wood D; Keil U;
    Eur J Prev Cardiol; 2015 Sep; 22(9):1212-9. PubMed ID: 25516535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pursuit of secondary prevention targets in Czech coronary patients. A comparison of EuroAspire I and II surveys.
    Mayer O; Simon J; Rosolová H; De Bacquer D;
    Cent Eur J Public Health; 2002 Sep; 10(3):107-11. PubMed ID: 12298341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood pressure is insufficiently controlled in European patients with established coronary heart disease.
    Boersma E; Keil U; De Bacquer D; De Backer G; Pyörälä K; Poldermans D; Leprotti C; Pilotto L; de Swart E; Deckers JW; Heidrich J; Sans S; Kotseva K; Wood D; Ambrosio GB;
    J Hypertens; 2003 Oct; 21(10):1831-40. PubMed ID: 14508188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of coronary artery disease in Kyrgyzstan: a comparison with Turkey and europe according to European Action on Primary and secondary prevention by intervention to reduce events III results.
    Kutlu R; Muratalievic TM; Memetoglu ME
    Turk Kardiyol Dern Ars; 2014 Sep; 42(6):545-52. PubMed ID: 25362945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology.
    De Backer G; Besseling J; Chapman J; Hovingh GK; Kastelein JJ; Kotseva K; Ray K; Reiner Ž; Wood D; De Bacquer D;
    Atherosclerosis; 2015 Jul; 241(1):169-75. PubMed ID: 25997074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study.
    De Bacquer D; De Smedt D; Kotseva K; Jennings C; Wood D; Rydén L; Gyberg V; Shahim B; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D; Wagner M; De Backer G;
    Eur J Epidemiol; 2019 Mar; 34(3):247-258. PubMed ID: 30353266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Secondary prevention of coronary heart disease. Results from EuroASPIRE I and II in the region of Münster, Germany].
    Heidrich J; Liese AD; Kalic M; Winter-Enbergs A; Wellmann J; Roeder N; Kerber S; Breithardt G; Scheld HH; Kleine-Katthöfer P; Keil U
    Dtsch Med Wochenschr; 2002 Mar; 127(13):667-72. PubMed ID: 11928058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Lancet; 2009 Mar; 373(9667):929-40. PubMed ID: 19286092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
    Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D;
    Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoking cessation in European patients with coronary heart disease. Results from the EUROASPIRE IV survey: A registry from the European Society of Cardiology.
    Snaterse M; Deckers JW; Lenzen MJ; Jorstad HT; De Bacquer D; Peters RJG; Jennings C; Kotseva K; Scholte Op Reimer WJM;
    Int J Cardiol; 2018 May; 258():1-6. PubMed ID: 29544918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of the English Version of the HeartQoL Health-Related Quality of Life Questionnaire in Patients With Coronary Heart Disease.
    Oldridge N; Cho C; Thomas R; Low M; Höfer S
    J Cardiopulm Rehabil Prev; 2018 Mar; 38(2):92-99. PubMed ID: 28671935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender gap in risk factor control of coronary patients far from closing: results from the European Society of Cardiology EUROASPIRE V registry.
    Vynckier P; Ferrannini G; Rydén L; Jankowski P; De Backer T; Gevaert S; De Bacquer D; De Smedt D;
    Eur J Prev Cardiol; 2022 Mar; 29(2):344-351. PubMed ID: 33624111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).
    Bowker TJ; Clayton TC; Ingham J; McLennan NR; Hobson HL; Pyke SD; Schofield B; Wood DA
    Heart; 1996 Apr; 75(4):334-42. PubMed ID: 8705756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regular exercise behaviour and intention and symptoms of anxiety and depression in coronary heart disease patients across Europe: Results from the EUROASPIRE III survey.
    Prugger C; Wellmann J; Heidrich J; De Bacquer D; De Smedt D; De Backer G; Reiner Ž; Empana JP; Fras Z; Gaita D; Jennings C; Kotseva K; Wood D; Keil U;
    Eur J Prev Cardiol; 2017 Jan; 24(1):84-91. PubMed ID: 27587188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender differences in health-related quality of life and psychological distress among coronary patients: Does comorbidity matter? Results from the ESC EORP EUROASPIRE V registry.
    Vynckier P; Van Wilder L; Kotseva K; Wood D; Gevaert S; Clays E; De Bacquer D; De Smedt D;
    Int J Cardiol; 2023 Jan; 371():452-459. PubMed ID: 36087631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.